74.75 3.35 (4.69%)

32.05% Fall from 52W High

1,010 BSE Volume

BSEDec 03, 2021 03:31 PM



Eiko Lifesciences Ltd.    
22 Nov 2021
74.75
4.69%
Eiko Lifesciences Ltd.    
03 Nov 2021
74.75
4.69%
Eiko Lifesciences Ltd.    
02 Nov 2021
74.75
4.69%
Eiko Lifesciences Ltd.    
20 Oct 2021
74.75
4.69%
Eiko Lifesciences Ltd.    
08 Oct 2021
74.75
4.69%
Eiko Lifesciences Ltd.    
07 Oct 2021
74.75
4.69%
Eiko Lifesciences Ltd.    
07 Oct 2021
74.75
4.69%
Eiko Lifesciences Ltd - 540204 - Shareholding for the Period Ended September 30, 2021
BSE India
Eiko Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2021. For more details, kindly Click here
Eiko Lifesciences Ltd.    
06 Oct 2021
74.75
4.69%
Eiko Lifesciences Ltd - 540204 - Statement Of Investor Complaints For The Quarter Ended September 2021
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Avi Vijaykumar MundechaDesignation :- Company Secretary and Compliance Officer
default
Eiko Lifesciences Ltd.    
30 Sep 2021
74.75
4.69%
Eiko Lifesciences Ltd - 540204 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
BSE India
Eiko Lifesciences Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
Eiko Lifesciences Ltd.    
30 Sep 2021
74.75
4.69%
Eiko Lifesciences Ltd - 540204 - Closure of Trading Window
BSE India
This is to inform you that pursuant to the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Company''s Code of Conduct to Regulate, Monitor and Report Trading by designated persons & their immediate relatives (including all insiders), the Trading Window in respect of dealings in the Equity Shares of the Company, will remain closed, for all the designated persons of the Company & their immediate relatives (including all insiders ), with effect from 01st October, 2021 till the end of forty eight hours after the declaration of the Un-audited Financial Results of the Company for the quarter and half-year ending 30th September, 2021.